Want to see ORKA full AI Analyst Report?
Oruka Therapeutics (ORKA) Ownership - Who Owns Oruka Therapeutics?
Oruka Therapeutics (ORKA) Ownership Overview
- 7.67% Insiders
- 29.71% Mutual Funds
- 0.32% Other Institutional Investors
- 15.24% ETFs
- 47.06% Public Companies and Individual Investors
The ownership structure of Oruka Therapeutics (ORKA) stock is a mix of institutional, retail, and individual investors. Approximately 45.27% of the company’s stock is owned by Institutional Investors, 7.67% is owned by Insiders, and 47.06% is owned by Public Companies and Individual Investors.
The ownership structure of Oruka Therapeutics (ORKA) stock is a mix of institutional, retail, and individual investors. Approximately 30.03% of the company’s stock is owned by Institutional Investors, 7.67% is owned by Insiders, and 15.24% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| Sep 14, 2026 | Laura Lee Sandler | $86,713 | |
| Sep 14, 2026 | Paul T. Quinlan | $99,443 | |
| Sep 14, 2026 | Lawrence Otto Klein | $234,681 | |
| Jun 30, 2026 | Fairmount Funds Management Llc | $300,014,406 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2026 | Perceptive Advisors Llc | $128,009,646 | |
| Jun 30, 2026 | Woodline Partners Lp | $27,146,957 | |
| Jun 30, 2026 | Blackstone Inc. | $22,565,568 | |
| Jun 30, 2026 | Viking Global Investors Lp | $143,086,001 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 4,155,446 | Institution | 6.28% | 402,538,054 |
| Fairmount Funds Management Llc | 3,705,262 | Insider | 5.60% | 358,928,730 |
| Peter Harwin | 3,705,262 | Institution | 5.60% | 358,928,730 |
| Ishares | 2,506,748 | Institution | 3.79% | 242,828,679 |
| Vanguard Index Funds | 2,305,645 | Institution | 3.48% | 223,347,831 |
| Fidelity Mt. Vernon Street Trust | 2,015,491 | Institution | 3.04% | 195,240,613 |
| Spdr | 1,876,755 | Institution | 2.83% | 181,801,257 |
| Peter Kolchinsky | 1,554,597 | Institution | 2.35% | 150,593,811 |
| Smallcap World Fund Inc | 1,527,592 | Institution | 2.31% | 147,977,837 |
| Andreas Halvorsen | 1,503,478 | Institution | 2.27% | 145,641,914 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 2,305,645 | Institution | 3.48% | 223,347,831 |
| Fidelity Mt. Vernon Street Trust | 2,015,491 | Institution | 3.04% | 195,240,613 |
| Smallcap World Fund Inc | 1,527,592 | Institution | 2.31% | 147,977,837 |
| Fidelity Securities Fund | 1,462,630 | Institution | 2.21% | 141,684,968 |
| Fidelity Select Portfolios | 1,442,683 | Institution | 2.18% | 139,752,702 |
| New Economy Fund | 1,323,308 | Institution | 2.00% | 128,188,846 |
| Fidelity Advisor Series Vii | 1,165,386 | Institution | 1.76% | 112,890,942 |
| Fidelity Salem Street Trust | 725,381 | Institution | 1.10% | 70,267,657 |
| Fidelity Concord Street Trust | 513,840 | Institution | 0.78% | 49,775,681 |
| Franklin Strategic Series | 504,275 | Institution | 0.76% | 48,849,119 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard | 1,900,592 | Institution | 2.87% | 158,300,308 |
| SPDR | 1,687,380 | Institution | 2.55% | 163,085,277 |
| iShares | 1,282,031 | Institution | 1.94% | 123,908,296 |
| Vanguard | 669,697 | Institution | 1.01% | 55,779,063 |
| Vanguard | 641,418 | Institution | 0.97% | 53,423,705 |
| iShares | 474,283 | Institution | 0.72% | 45,943,794 |
| iShares | 459,318 | Institution | 0.69% | 44,494,135 |
| Vanguard | 373,672 | Institution | 0.56% | 31,123,141 |
| Schwab | 301,532 | Institution | 0.46% | 29,143,068 |
| Vanguard | 292,775 | Institution | 0.44% | 24,385,230 |
FAQ
Who Owns Oruka Therapeutics (ORKA)?
According to the latest TipRanks data, approximately 0.32% of the company's stock is held by institutional investors, 7.67% is held by insiders, and 47.06% is held by retail investors.
What percentage of Oruka Therapeutics (ORKA) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.32% of Oruka Therapeutics (ORKA) stock is held by institutional investors.
What percentage of Oruka Therapeutics (ORKA) stock is held by retail investors?
According to the latest TipRanks data, approximately 47.06% of Oruka Therapeutics (ORKA) stock is held by retail investors.
Who owns the most shares of Oruka Therapeutics (ORKA)?
Vanguard owns the most shares of Oruka Therapeutics (ORKA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.